December 28, 2014 10:41 PM ET

Healthcare Providers and Services

Company Overview of 23andMe, Inc.

Company Overview

23andMe, Inc. operates as a personal genetics company that provides ancestry-related genetic reports and uninterpreted raw genetic data. The company helps individuals understand their own genetic information through DNA analysis technologies and Web-based interactive tools. Its Personal Genome Service enables individuals to gain deeper insights into their ancestry and inherited traits. The company was founded in 2006 and is based in Mountain View, California.

1390 Shorebird Way

Mountain View, CA 94043

United States

Founded in 2006





Key Executives for 23andMe, Inc.

President and Director
Age: 47
Chief Medical Officer
Chief Legal and Regulatory Officer
Age: 50
Vice President of Communications
Compensation as of Fiscal Year 2014.

23andMe, Inc. Key Developments

23andMe Appoints Ruby Gadelrab as Vice President, Commercial Marketing

23andMe announced the appointment of Ruby Gadelrab as vice president, commercial marketing. Gadelrab will oversee the global marketing efforts for the company's industry and academic collaborations. Before joining 23andMe, Gadelrab served as head of marketing and commercial development at Invitae Corporation. Prior to joining Invitae, Gadelrab worked at Affymetrix, Inc., where she most recently served as head of international marketing and clinical development.

23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease

23andMe, Inc. announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. The collaboration represents an innovative effort for both companies designed to explore the underlying genetics of IBD and it is hoped that the effort will ultimately lead to potential new or improved treatments for IBD. All study participants will receive 23andMe's Personal Genome Service(R) at no cost, including their ancestry analysis and uninterpreted raw genetic data. 23andMe will recruit individuals who are not current 23andMe customers and have also been diagnosed with Crohn's disease or ulcerative colitis by a qualified physician. Study participants will need to consent to provide a DNA sample (saliva), answer online surveys, and agree to share their data with researchers. The study is currently open to U.S. residents only.

23andMe Appoints Angela Wonson as VP of Communications

23andMe, Inc. announced that it has appointed Angela Wonson as vice president, communications. The company said that Wonson brings more than 18 years of communications experience in the health care, science and technology industries to 23andMe. She will oversee the company's corporate communications, media relations, investor relations and internal communications activities. Prior to joining 23andMe, Wonson served as vice president of communications and senior media advisor at Intuitive Surgical. Prior to joining Intuitive Surgical, Wonson held senior positions in health care media relations at both Weber Shandwick and Edelman Public Relations.

Similar Private Companies By Industry

Company Name Region
Odyssey Healthcare of Las Vegas Inc. United States
Elk Grove Dialysis Center, LLC United States
The Rockville MD Endoscopy ASC, LLC United States
Prime Healthcare, PC United States
HHC Poplar Springs, Inc. United States

Recent Private Companies Transactions

Private Placement
October 22, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 23andMe, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at